EcoDrugPlus

Ensembl ID : ENSBBBG00000002380
Gene Symbol: -
Cross references: -
273 Possible Orthologues:

Ensembl ID : ENSBBBG00000001578
Gene Symbol: -
Cross references: -
264 Possible Orthologues:

Ensembl ID : ENSBBBG00000005213
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Ensembl ID : ENSBBBG00000007956
Gene Symbol: -
Cross references: -
164 Possible Orthologues:

Ensembl ID : ENSBBBG00000007889
Gene Symbol: -
Cross references: -
234 Possible Orthologues:

Ensembl ID : ENSBBBG00000006628
Gene Symbol: -
Cross references: -
238 Possible Orthologues:

Ensembl ID : ENSBBBG00000006294
Gene Symbol: -
Cross references: -
238 Possible Orthologues:

Ensembl ID : ENSBBBG00000003525
Gene Symbol: -
Cross references: -
251 Possible Orthologues:

Ensembl ID : ENSBBBG00000001689
Gene Symbol: -
Cross references: -
229 Possible Orthologues:

Ensembl ID : ENSBBBG00000008109
Gene Symbol: -
Cross references: -
212 Possible Orthologues:

Ensembl ID : ENSBBBG00000000913
Gene Symbol: -
Cross references: -
222 Possible Orthologues:

Ensembl ID : ENSBBBG00000005586
Gene Symbol: -
Cross references: -
141 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).